Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) Net Margin (2020 - 2025)

Historic Net Margin for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to 25.7%.

  • PROCEPT BioRobotics' Net Margin rose 102400.0% to 25.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 28.2%, marking a year-over-year increase of 218700.0%. This contributed to the annual value of 40.72% for FY2024, which is 370400.0% up from last year.
  • Per PROCEPT BioRobotics' latest filing, its Net Margin stood at 25.7% for Q3 2025, which was up 102400.0% from 24.73% recorded in Q2 2025.
  • PROCEPT BioRobotics' Net Margin's 5-year high stood at 24.73% during Q2 2025, with a 5-year trough of 180.98% in Q4 2021.
  • Moreover, its 5-year median value for Net Margin was 76.38% (2023), whereas its average is 90.96%.
  • In the last 5 years, PROCEPT BioRobotics' Net Margin surged by 4072100bps in 2021 and then soared by 43300bps in 2023.
  • PROCEPT BioRobotics' Net Margin (Quarter) stood at 180.98% in 2021, then surged by 42bps to 104.78% in 2022, then surged by 40bps to 63.11% in 2023, then soared by 56bps to 27.63% in 2024, then grew by 7bps to 25.7% in 2025.
  • Its Net Margin stands at 25.7% for Q3 2025, versus 24.73% for Q2 2025 and 35.77% for Q1 2025.